{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:56:26Z","timestamp":1781787386612,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00403-019-01992-z","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T12:46:02Z","timestamp":1576068362000},"page":"373-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tanshinol inhibits growth of malignant melanoma cells via regulating miR-1207-5p\/CHPF pathway"],"prefix":"10.1007","volume":"312","author":[{"given":"Yujie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diancai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"1992_CR1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.18632\/oncotarget.1825","volume":"5","author":"M Agostini","year":"2014","unstructured":"Agostini M, Knight RA (2014) miR-34: from bench to bedside. Oncotarget 5:872\u2013881. https:\/\/doi.org\/10.18632\/oncotarget.1825","journal-title":"Oncotarget"},{"key":"1992_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13073-016-0284-1","volume":"8","author":"MI Almeida","year":"2016","unstructured":"Almeida MI, Calin GA (2016) The miR-143\/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med 8:29. https:\/\/doi.org\/10.1186\/s13073-016-0284-1","journal-title":"Genome Med"},{"key":"1992_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.revinf.2015.12.022","author":"B Baroudjian","year":"2016","unstructured":"Baroudjian B, Pages C, Lebbe C (2016) Melanoma, from diagnosis to treatment. Revue de l'infirmiere. https:\/\/doi.org\/10.1016\/j.revinf.2015.12.022","journal-title":"Revue de l'infirmiere"},{"key":"1992_CR4","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-07-2912","volume":"68","author":"LT Bemis","year":"2008","unstructured":"Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG, Erickson PF, Shellman YG, Robinson WA (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68:1362\u20131368. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2912","journal-title":"Cancer Res"},{"key":"1992_CR5","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1038\/cddis.2013.553","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen L, Lu MH, Zhang D, Hao NB, Fan YH, Wu YY, Wang SM, Xie R, Fang DC, Zhang H, Hu CJ, Yang SM (2014) miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis 5:e1034. https:\/\/doi.org\/10.1038\/cddis.2013.553","journal-title":"Cell Death Dis"},{"key":"1992_CR6","doi-asserted-by":"publisher","first-page":"32421","DOI":"10.18632\/oncotarget.8718","volume":"7","author":"W Dang","year":"2016","unstructured":"Dang W, Qin Z, Fan S, Wen Q, Lu Y, Wang J, Zhang X, Wei L, He W, Ye Q, Yan Q, Li G, Ma J (2016) miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1. Oncotarget 7:32421\u201332432. https:\/\/doi.org\/10.18632\/oncotarget.8718","journal-title":"Oncotarget"},{"key":"1992_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ITT.S134842","volume":"7","author":"B Domingues","year":"2018","unstructured":"Domingues B, Lopes JM, Soares P, Populo H (2018) Melanoma treatment in review. ImmunoTargets Ther 7:35\u201349. https:\/\/doi.org\/10.2147\/ITT.S134842","journal-title":"ImmunoTargets Ther"},{"key":"1992_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3892\/or.2017.5731","volume":"38","author":"YH Fan","year":"2017","unstructured":"Fan YH, Xiao B, Lv SG, Ye MH, Zhu XG, Wu MJ (2017) Lentivirusmediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro. Oncol Rep 38:1149\u20131155. https:\/\/doi.org\/10.3892\/or.2017.5731","journal-title":"Oncol Rep"},{"key":"1992_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3892\/br.2016.747","volume":"5","author":"YH Feng","year":"2016","unstructured":"Feng YH, Tsao CJ (2016) Emerging role of microRNA-21 in cancer. Biomed Rep 5:395\u2013402. https:\/\/doi.org\/10.3892\/br.2016.747","journal-title":"Biomed Rep"},{"key":"1992_CR10","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/S1470-2045(19)30099-3","volume":"20","author":"V Franke","year":"2019","unstructured":"Franke V, van Akkooi ACJ (2019) The extent of surgery for stage III melanoma: how much is appropriate? Lancet Oncol 20:e167\u2013e174. https:\/\/doi.org\/10.1016\/S1470-2045(19)30099-3","journal-title":"Lancet Oncol"},{"key":"1992_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11030326","author":"A Gajos-Michniewicz","year":"2019","unstructured":"Gajos-Michniewicz A, Czyz M (2019) Role of miRNAs in melanoma metastasis. Cancers. https:\/\/doi.org\/10.3390\/cancers11030326","journal-title":"Cancers"},{"key":"1992_CR12","doi-asserted-by":"publisher","first-page":"33720","DOI":"10.1038\/srep33720","volume":"6","author":"H Gao","year":"2016","unstructured":"Gao H, Sun W, Zhao J, Wu X, Lu JJ, Chen X, Xu QM, Khan IA, Yang S (2016) Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen). Sci Rep 6:33720. https:\/\/doi.org\/10.1038\/srep33720","journal-title":"Sci Rep"},{"key":"1992_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert LFR, MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20:21\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0045-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1992_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1992_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3892\/ol.2018.9687","volume":"17","author":"X Hou","year":"2019","unstructured":"Hou X, Niu Z, Liu L, Guo Q, Li H, Yang X, Zhang X (2019) miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression. Oncol Lett 17:990\u2013998. https:\/\/doi.org\/10.3892\/ol.2018.9687","journal-title":"Oncol Lett"},{"key":"1992_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.02.005","author":"XM Hou","year":"2019","unstructured":"Hou XM, Zhang T, Da Z, Wu XA (2019) CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway. Pathol Res Pract. https:\/\/doi.org\/10.1016\/j.prp.2019.02.005","journal-title":"Pathol Res Pract"},{"key":"1992_CR17","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1002\/cncr.28354","volume":"119","author":"S Hwang","year":"2013","unstructured":"Hwang S, Mahadevan S, Qadir F, Hutchison IL, Costea DE, Neppelberg E, Liavaag PG, Waseem A, Teh MT (2013) Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas. Cancer 119:4249\u20134258. https:\/\/doi.org\/10.1002\/cncr.28354","journal-title":"Cancer"},{"key":"1992_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","volume":"1871","author":"I Kozar","year":"2019","unstructured":"Kozar I, Margue C, Rothengatter S, Haan C, Kreis S (2019) Many ways to resistance: How melanoma cells evade targeted therapies. Biochim Biophys Acta 1871:313\u2013322. https:\/\/doi.org\/10.1016\/j.bbcan.2019.02.002","journal-title":"Biochim Biophys Acta"},{"key":"1992_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1582-4934.2008.00556.x","volume":"13","author":"AM Krichevsky","year":"2009","unstructured":"Krichevsky AM, Gabriely G (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13:39\u201353. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00556.x","journal-title":"J Cell Mol Med"},{"key":"1992_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3892\/ijo.2018.4287","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi GC, Falzone L, Salemi R, Zanghi A, Spandidos DA, McCubrey JA, Candido S, Libra M (2018) Cutaneous melanoma: from pathogenesis to therapy (Review). Int J Oncol 52:1071\u20131080. https:\/\/doi.org\/10.3892\/ijo.2018.4287","journal-title":"Int J Oncol"},{"key":"1992_CR21","first-page":"103","volume":"83","author":"C McCourt","year":"2014","unstructured":"McCourt C, Dolan O, Gormley G (2014) Malignant melanoma: a pictorial review. Ulster Med J 83:103\u2013110","journal-title":"Ulster Med J"},{"key":"1992_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O'Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol"},{"key":"1992_CR23","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM (2016) The role of MicroRNAs in human cancer. Signal Transduct Target Ther 1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4","journal-title":"Signal Transduct Target Ther"},{"key":"1992_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S (2018) Melanoma Lancet 392:971\u2013984. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9","journal-title":"Melanoma Lancet"},{"key":"1992_CR25","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.2147\/OTT.S101310","volume":"9","author":"ED Shen","year":"2016","unstructured":"Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY (2016) The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma. OncoTargets Ther 9:3633\u20133642. https:\/\/doi.org\/10.2147\/OTT.S101310","journal-title":"OncoTargets Ther"},{"key":"1992_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gene.2018.09.032","volume":"680","author":"P Song","year":"2019","unstructured":"Song P, Yin SC (2019) Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p\/KLF12 axis. Gene 680:51\u201358. https:\/\/doi.org\/10.1016\/j.gene.2018.09.032","journal-title":"Gene"},{"key":"1992_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/13543776.2013.736494","volume":"23","author":"XH Tian","year":"2013","unstructured":"Tian XH, Wu JH (2013) Tanshinone derivatives: a patent review (January 2006\u2013September 2012). Expert Opin Ther Pat 23:19\u201329. https:\/\/doi.org\/10.1517\/13543776.2013.736494","journal-title":"Expert Opin Ther Pat"},{"key":"1992_CR28","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.7754\/Clin.Lab.2017.170625","volume":"63","author":"X Wang","year":"2017","unstructured":"Wang X, Wu X (2017) The role of MicroRNA-1207-5p in colorectal cancer. Clin Lab 63:1875\u20131882. https:\/\/doi.org\/10.7754\/Clin.Lab.2017.170625","journal-title":"Clin Lab"},{"key":"1992_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030368","author":"S Wrobel","year":"2019","unstructured":"Wrobel S, Przybylo M, Stepien E (2019) The clinical trial landscape for melanoma therapies. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8030368","journal-title":"J Clin Med"},{"key":"1992_CR30","doi-asserted-by":"publisher","first-page":"90925","DOI":"10.18632\/oncotarget.18767","volume":"8","author":"CY Wu","year":"2017","unstructured":"Wu CY, Cherng JY, Yang YH, Lin CL, Kuan FC, Lin YY, Lin YS, Shu LH, Cheng YC, Liu HT, Lu MC, Lung J, Chen PC, Lin HK, Lee KD, Tsai YH (2017) Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells. Oncotarget 8:90925\u201390947. https:\/\/doi.org\/10.18632\/oncotarget.18767","journal-title":"Oncotarget"},{"key":"1992_CR31","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1002\/cam4.1781","volume":"7","author":"H Xu","year":"2018","unstructured":"Xu H, Hao YL, Xu LN, Chen L, Xu FW (2018) Tanshinone sensitized the antitumor effects of irradiation on laryngeal cancer via JNK pathway. Cancer Med 7:5187\u20135193. https:\/\/doi.org\/10.1002\/cam4.1781","journal-title":"Cancer Med"},{"key":"1992_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/cas.13212","volume":"108","author":"C Yan","year":"2017","unstructured":"Yan C, Chen Y, Kong W, Fu L, Liu Y, Yao Q, Yuan Y (2017) PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6. Cancer Sci 108:868\u2013876. https:\/\/doi.org\/10.1111\/cas.13212","journal-title":"Cancer Sci"},{"key":"1992_CR33","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3892\/ijo.2015.2900","volume":"46","author":"X Yang","year":"2015","unstructured":"Yang X, Zang W, Xuan X, Wang Z, Liu Z, Wang J, Cui J, Zhao G (2015) miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma. Int J Oncol 46:2163\u20132171. https:\/\/doi.org\/10.3892\/ijo.2015.2900","journal-title":"Int J Oncol"},{"key":"1992_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12967-018-1728-8","volume":"16","author":"W Zhang","year":"2018","unstructured":"Zhang W, Lin Y, Liu X, He X, Zhang Y, Fu W, Yang Z, Yang P, Wang J, Hu K, Zhang X, Liu W, Yuan X, Jing H (2018) Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma. J Transl Med 16:363. https:\/\/doi.org\/10.1186\/s12967-018-1728-8","journal-title":"J Transl Med"},{"key":"1992_CR35","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.3390\/ijms131013621","volume":"13","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Jiang P, Ye M, Kim SH, Jiang C, Lu J (2012) Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci 13:13621\u201313666. https:\/\/doi.org\/10.3390\/ijms131013621","journal-title":"Int J Mol Sci"},{"key":"1992_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/OTT.S185997","volume":"12","author":"P Zhu","year":"2019","unstructured":"Zhu P, Liu Z, Zhou J, Chen Y (2019) Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway. OncoTargets Ther 12:87\u201399. https:\/\/doi.org\/10.2147\/OTT.S185997","journal-title":"OncoTargets Ther"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01992-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-019-01992-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01992-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:49:18Z","timestamp":1607561358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-019-01992-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1992"],"URL":"https:\/\/doi.org\/10.1007\/s00403-019-01992-z","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"31 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of human participants were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}